Lenox Wealth Advisors’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Lenox Wealth Advisors’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-83	Closed	-$4K	–	586
2015 Q3	$4K	Buy	83 +54	+186%	+$2.28K	﹤0.01%	293
2015 Q2	$1K	Buy	+29	New	+$1.22K	﹤0.01%	291

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Lenox Wealth Advisors's WX Position: Q4 2015 in Review

Lenox Wealth Advisors sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 83 shares — an estimated $4K sold.

Lenox Wealth Advisors first reported a position in WX in Q2 2015 and held it in 2 quarters. The position peaked at $4K in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Lenox Wealth Advisors reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Lenox Wealth Advisors sold 83 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $4K.
Lenox Wealth Advisors first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2015 and held it in 2 quarters.
Lenox Wealth Advisors's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $4K in Q3 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Lenox Wealth Advisors's 13F filing for Q4 2015, filed 8 Jan 2016.